Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 19;11(11):2810.
doi: 10.3390/microorganisms11112810.

T Cell Response in Tuberculosis-Infected Patients Vaccinated against COVID-19

Affiliations

T Cell Response in Tuberculosis-Infected Patients Vaccinated against COVID-19

Luiz Henrique Agra Cavalcante-Silva et al. Microorganisms. .

Abstract

Many studies have focused on SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) co-infection consequences. However, after a vaccination plan against COVID-19, the cases of severe disease and death are consistently controlled, although cases of asymptomatic and mild COVID-19 still happen together with tuberculosis (TB) cases. Thus, in this context, we sought to compare the T cell response of COVID-19-non-vaccinated and -vaccinated patients with active tuberculosis exposed to SARS-CoV-2 antigens. Flow cytometry was used to analyze activation markers (i.e., CD69 and CD137) and cytokines (IFN-γ, TNFα, IL-17, and IL-10) levels in CD4+ and CD8+ T cells upon exposure to SARS-CoV-2 peptides. The data obtained showed that CD8+ T cells from non-vaccinated TB patients present a high frequency of CD69 and TNF-α after viral challenge compared to vaccinated TB donors. Conversely, CD4+ T cells from vaccinated TB patients show a high frequency of IL-10 after spike peptide stimulus compared to non-vaccinated patients. No differences were observed in the other parameters analyzed. The results suggest that this reduced immune balance in coinfected individuals may have consequences for pathogen control, necessitating further research to understand its impact on clinical outcomes after COVID-19 vaccination in those with concurrent SARS-CoV-2 and Mtb infections.

Keywords: immune response; infection; lymphocytes; vaccines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Profile of activation markers in T cells. (a) CD69 and (b) CD137 expression in CD4+ T cells. (c) CD69 and (d) CD137 expression in CD8+ T cells. Graphs are expressed as mean ± standard error (SEM). * p < 0.05, **** p < 0.0001, # p < 0.05 medium vs. SEB within each group, b p < 0.05 NTB medium vs. HC medium, § p < 0.05 HC vs. NTB; HC = healthy control (n = 9); NTB = non-vaccinated with active tuberculosis (n = 3); VTB = vaccinated with active tuberculosis (n = 8). PS = Pool Spike Cov-2; PT = Pool CoV-2; SEB = staphylococcal enterotoxin B.
Figure 2
Figure 2
Profile of cytokines in CD4+ T cells. (a) TNF-α, (b) IFN-γ, (c) IL-17, and (d) IL-10. Graphs are expressed as mean ± standard error (SEM). * p < 0.05, **** p < 0.0001, § p < 0.05 HC vs. NTB; HC = healthy control (n = 9); NTB = non-vaccinated with active tuberculosis (n = 3); VTB = vaccinated with active tuberculosis (n = 8). PS = Pool Spike Cov-2; PT = Pool CoV-2; SEB = staphylococcal enterotoxin B.
Figure 3
Figure 3
Profile of cytokines in CD8+ T cells. (a) TNF-α, (b) IFN-γ, (c) IL-17, (d) IL-10. Graphs are expressed as mean ± standard error (SEM). ** p < 0.01, a p < 0.05 HC PT vs. HC medium, § p < 0.05 HC vs. NTB; HC = healthy control (n = 9); NTB = non-vaccinated with active tuberculosis (n = 3); VTB = vaccinated with active tuberculosis (n = 8). PS = Pool Spike Cov-2; PT = Pool CoV-2; SEB = staphylococcal enterotoxin B.
Figure 4
Figure 4
Radar charts of immune profile of CD4+ and CD8+ T cells. HC = healthy control (n = 9); NTB = non-vaccinated with active tuberculosis (n = 3); VTB = vaccinated with active tuberculosis (n = 8). PS = Pool Spike Cov-2; PT = Pool CoV-2.

References

    1. Shah T., Shah Z., Yasmeen N., Baloch Z., Xia X. Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection. Front. Immunol. 2022;13:909011. doi: 10.3389/fimmu.2022.909011. - DOI - PMC - PubMed
    1. Tan L.Y., Komarasamy T.V., RMT Balasubramaniam V. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Front. Immunol. 2021;12:742941. doi: 10.3389/fimmu.2021.742941. - DOI - PMC - PubMed
    1. Ravimohan S., Kornfeld H., Weissman D., Bisson G.P. Tuberculosis and lung damage: From epidemiology to pathophysiology. Eur. Respir. Rev. 2018;27:170077. doi: 10.1183/16000617.0077-2017. - DOI - PMC - PubMed
    1. Muefong C.N., Sutherland J.S. Neutrophils in Tuberculosis-Associated Inflammation and Lung Pathology. Front. Immunol. 2020;11:539802. doi: 10.3389/fimmu.2020.00962. - DOI - PMC - PubMed
    1. Kang T.G., Kwon K.W., Kim K., Lee I., Kim M.J., Ha S.J., Shin S.J. Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx. Nat. Commun. 2022;13:3155. doi: 10.1038/s41467-022-30914-3. - DOI - PMC - PubMed